130 related articles for article (PubMed ID: 9491667)
1. Secondary ANLL with t(11;19)(q23;p13) following etoposide and cisplatin for ovarian germ cell tumor.
Kapoor G; Kadam PR; Chougule A; Gladstone B; Advani SH
Indian J Cancer; 1997 Jun; 34(2):84-7. PubMed ID: 9491667
[TBL] [Abstract][Full Text] [Related]
2. Outcome and reproductive function after cumulative high-dose combination chemotherapy with bleomycin, etoposide and cisplatin (BEP) for patients with ovarian endodermal sinus tumor.
Kang H; Kim TJ; Kim WY; Choi CH; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2008 Oct; 111(1):106-10. PubMed ID: 18656249
[TBL] [Abstract][Full Text] [Related]
3. Favorable outcome of ovarian germ cell malignancies treated with cisplatin or carboplatin-based chemotherapy: a Hellenic Cooperative Oncology Group study.
Dimopoulos MA; Papadopoulou M; Andreopoulou E; Papadimitriou C; Pavlidis N; Aravantinos G; Aspropotamitis A; Anagnostopoulos A; Fountzilas G; Michalas S; Pectacides D
Gynecol Oncol; 1998 Jul; 70(1):70-4. PubMed ID: 9698477
[TBL] [Abstract][Full Text] [Related]
4. Secondary leukemia associated with a conventional dose of etoposide: review of serial germ cell tumor protocols.
Nichols CR; Breeden ES; Loehrer PJ; Williams SD; Einhorn LH
J Natl Cancer Inst; 1993 Jan; 85(1):36-40. PubMed ID: 7677934
[TBL] [Abstract][Full Text] [Related]
5. [Therapy-related AML(M2) with t(8;21) that developed three years after chemotherapy for hepatocellular carcinoma].
Miyata A; Deguchi S; Fujita M; Kikuchi T; Honda K
Rinsho Ketsueki; 1996 May; 37(5):448-51. PubMed ID: 8691593
[TBL] [Abstract][Full Text] [Related]
6. Long-term results of first-line sequential high-dose etoposide, ifosfamide, and cisplatin chemotherapy plus autologous stem cell support for patients with advanced metastatic germ cell cancer: an extended phase I/II study of the German Testicular Cancer Study Group.
Schmoll HJ; Kollmannsberger C; Metzner B; Hartmann JT; Schleucher N; Schöffski P; Schleicher J; Rick O; Beyer J; Hossfeld D; Kanz L; Berdel WE; Andreesen R; Bokemeyer C;
J Clin Oncol; 2003 Nov; 21(22):4083-91. PubMed ID: 14568987
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of 129 patients with advanced and recurrent malignant ovarian germ cell tumor].
Hong W; Zhang R; Liu L
Zhonghua Fu Chan Ke Za Zhi; 1998 Jan; 33(1):35-7. PubMed ID: 10682456
[TBL] [Abstract][Full Text] [Related]
8. Treatment of children and adolescents with stage II testicular and stages I and II ovarian malignant germ cell tumors: A Pediatric Intergroup Study--Pediatric Oncology Group 9048 and Children's Cancer Group 8891.
Rogers PC; Olson TA; Cullen JW; Billmire DF; Marina N; Rescorla F; Davis MM; London WB; Lauer SJ; Giller RH; Cushing B; ;
J Clin Oncol; 2004 Sep; 22(17):3563-9. PubMed ID: 15337806
[TBL] [Abstract][Full Text] [Related]
9. Translocation (X;10) in a child with therapy-related acute myeloid leukemia following chemotherapy for Ewing's Sarcoma.
Abla O; Dror Y; Shago M
Cancer Genet Cytogenet; 2007 Oct; 178(2):168-9. PubMed ID: 17954276
[No Abstract] [Full Text] [Related]
10. High-dose cisplatinum, vinblastine, bleomycin, and etoposide in the therapy of malignant nondysgerminomatous germ cell tumors of the ovary.
von Eyben FE
Gynecol Oncol; 1995 Jul; 58(1):143. PubMed ID: 7540585
[No Abstract] [Full Text] [Related]
11. Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter study.
Dimopoulos MA; Papadimitriou C; Hamilos G; Efstathiou E; Vlahos G; Rodolakis A; Aravantinos G; Kalofonos H; Kouroussis C; Gika D; Skarlos D; Bamias A
Gynecol Oncol; 2004 Dec; 95(3):695-700. PubMed ID: 15581984
[TBL] [Abstract][Full Text] [Related]
12. Secondary leukemia in a child with neuroblastoma while on oral etoposide: what is the cause?
Ng A; Taylor GM; Eden OB
Pediatr Hematol Oncol; 2000; 17(3):273-9. PubMed ID: 10779995
[TBL] [Abstract][Full Text] [Related]
13. Therapy-related myelodysplastic syndrome/acute myeloid leukemia M2 and translocation (8;21).
Sakugawa M; Kojima K; Kaneda K; Masuda K; Dansako H; Shinagawa K; Ishimaru F; Ikeda K; Niiya K; Harada M; Tanimoto M
Ann Hematol; 2001 Dec; 80(12):763-6. PubMed ID: 11797121
[TBL] [Abstract][Full Text] [Related]
14. Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.
Wierecky J; Kollmannsberger C; Boehlke I; Kuczyk M; Schleicher J; Schleucher N; Metzner B; Kanz L; Hartmann JT; Bokemeyer C
J Cancer Res Clin Oncol; 2005 Apr; 131(4):255-60. PubMed ID: 15627215
[TBL] [Abstract][Full Text] [Related]
15. Secondary leukemias in refractory germ cell tumor patients undergoing autologous stem-cell transplantation using high-dose etoposide.
Houck W; Abonour R; Vance G; Einhorn LH
J Clin Oncol; 2004 Jun; 22(11):2155-8. PubMed ID: 15169802
[TBL] [Abstract][Full Text] [Related]
16. Acute myelogenous leukemia after treatment for malignant germ cell tumors in children.
Schneider DT; Hilgenfeld E; Schwabe D; Behnisch W; Zoubek A; Wessalowski R; Göbel U
J Clin Oncol; 1999 Oct; 17(10):3226-33. PubMed ID: 10506623
[TBL] [Abstract][Full Text] [Related]
17. Disruption of the ETV6 gene as a consequence of a rare translocation (12;12)(p13;q13) in treatment-induced acute myeloid leukemia after breast cancer.
Manola KN; Georgakakos VN; Margaritis D; Stavropoulou C; Panos C; Kotsianidis I; Pantelias GE; Sambani C
Cancer Genet Cytogenet; 2008 Jan; 180(1):37-42. PubMed ID: 18068531
[TBL] [Abstract][Full Text] [Related]
18. Prognostic analysis of Japanese men with metastatic germ cell tumors showing favorable response to bleomycin, etoposide and cisplatin as first-line chemotherapy.
Kumano M; Miyake H; Hara I; Muramaki M; Takenaka A; Fujisawa M
Hinyokika Kiyo; 2007 Dec; 53(12):851-6. PubMed ID: 18203521
[TBL] [Abstract][Full Text] [Related]
19. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
Ogasawara T; Yasuyama M; Kawauchi K
Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
[TBL] [Abstract][Full Text] [Related]
20. [Treatment of malignant ovarian germ cell tumor and sex cord tumors].
Sugiyama T; Ohta S; Tomonari R; Kamura T
Gan To Kagaku Ryoho; 2002 Aug; 29(8):1358-62. PubMed ID: 12214461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
